Dynamic Technology Lab Private Ltd Increases Position in Simulations Plus, Inc. $SLP

by · The Cerbat Gem

Dynamic Technology Lab Private Ltd grew its holdings in shares of Simulations Plus, Inc. (NASDAQ:SLP – Free Report) by 58.8% during the second quarter, according to the company in its most recent disclosure with the SEC. The fund owned 16,541 shares of the technology company’s stock after buying an additional 6,128 shares during the quarter. Dynamic Technology Lab Private Ltd owned 0.08% of Simulations Plus worth $289,000 at the end of the most recent reporting period.

A number of other institutional investors and hedge funds have also recently modified their holdings of the business. Stephens Investment Management Group LLC purchased a new position in Simulations Plus during the 2nd quarter valued at $4,687,000. Wellington Management Group LLP bought a new stake in shares of Simulations Plus during the first quarter worth $2,458,000. Uniplan Investment Counsel Inc. boosted its stake in shares of Simulations Plus by 141.8% during the first quarter. Uniplan Investment Counsel Inc. now owns 144,202 shares of the technology company’s stock valued at $3,536,000 after purchasing an additional 84,562 shares during the period. Prescott Group Capital Management L.L.C. bought a new position in shares of Simulations Plus in the second quarter worth about $1,396,000. Finally, Envestnet Asset Management Inc. grew its holdings in shares of Simulations Plus by 95.4% in the second quarter. Envestnet Asset Management Inc. now owns 160,752 shares of the technology company’s stock worth $2,805,000 after purchasing an additional 78,466 shares during the last quarter. 78.08% of the stock is owned by institutional investors.

Simulations Plus Stock Down 0.3%

Simulations Plus stock opened at $17.13 on Wednesday. The firm has a market cap of $344.78 million, a P/E ratio of -5.44 and a beta of 0.98. The business has a fifty day moving average of $16.38 and a two-hundred day moving average of $18.02. Simulations Plus, Inc. has a twelve month low of $12.39 and a twelve month high of $37.67.

Wall Street Analysts Forecast Growth

SLP has been the subject of a number of research analyst reports. Cowen assumed coverage on shares of Simulations Plus in a report on Tuesday, September 30th. They set a “hold” rating for the company. KeyCorp reiterated a “sector weight” rating on shares of Simulations Plus in a report on Wednesday, October 29th. TD Cowen initiated coverage on Simulations Plus in a research note on Tuesday, September 30th. They issued a “hold” rating and a $16.00 price objective on the stock. Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Simulations Plus in a research report on Wednesday, October 8th. Finally, Citigroup reissued a “market perform” rating on shares of Simulations Plus in a research report on Tuesday, October 28th. One analyst has rated the stock with a Strong Buy rating, four have assigned a Buy rating, five have issued a Hold rating and one has issued a Sell rating to the company’s stock. Based on data from MarketBeat.com, Simulations Plus currently has a consensus rating of “Hold” and an average price target of $24.40.

Read Our Latest Stock Analysis on Simulations Plus

About Simulations Plus

(Free Report)

Simulations Plus, Inc develops drug discovery and development software for modeling and simulation, and prediction of molecular properties utilizing artificial intelligence and machine learning based technology worldwide. The company operates through two segments, Software and Services. It offers GastroPlus, which simulates the absorption and drug interaction of compounds administered to humans and animals; and DDDPlus and MembranePlus simulation products.

See Also